Model Number 7300TFX |
Device Problem
Perivalvular Leak (1457)
|
Patient Problems
Pleural Effusion (2010); Heart Failure/Congestive Heart Failure (4446)
|
Event Date 10/03/2023 |
Event Type
Injury
|
Event Description
|
Edwards received notification that a valve model 7300tfx29mm implanted in the mitral position was explanted after an implant duration of thirty four (34) days due to paravalvular leak (pvl).Reportedly, during index procedure the native mitral leaflets were found to be very calcified and thickened, leading to combined stenosis and regurgitation.During index procedure, the anterior mitral leaflet was excised with conservation of sub valvular apparatus.As reported, the initial post-op echoes were satisfactory.However, the patient developed heart failure and pleural effusions with recurrence of the ventricular septal defect (vsd) caused and repaired during debridement of aortic valve at the index procedure, presenting with poor hemodynamics for a third redo cardiac surgery.During reintervention, the mitral bioprosthesis was explanted and a non-edwards mechanical valve was implanted in replacement.Vsd repair with a pericardial patch and aortic valve replacement (avr) were performed concomitantly.Unfortunately, at the end of procedure, the patient had relatively poor hemodynamics and unfortunately passed away on the same day after leaving the theatre to be transferred for further intensive care management.
|
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.The device was not returned for evaluation, therefore customer report of perivalvular leak could not be confirmed by product evaluation.Regurgitation is considered to be a perivalvular leak (pvl) if a turbulent eccentric jet originates between the bioprosthetic sewing ring and the annulus.Pvl can occur in the mitral and aortic position for similar reasons.In the early postoperative period, the highest incidence of pvl has been seen in patients developing infective endocarditis, which is most likely attributed to inadequate peri-operative antibiotic prophylaxis or nosocomial infection.Annular calcification is also a risk factor for the development of peri-operative pvl as the bioprosthesis may not seat properly after debridement.Technique related factors, such as incorrect valve sizing, have been shown to contribute to the development of pvl.Anatomical factors may create difficulty seating the bioprosthetic valve resulting in pvl.The anatomy of the annulus may induce mechanical stresses along the rigid bioprosthetic ring which can influence long-term valve performance and durability.A diseased or rigid annulus can potentially increase the mechanical stress on the prosthetic valve, leading to pvl.The instructions for use (ifu) have been reviewed and no inadequacies have been identified with regard to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported type of event is included in the ifu.The most likely cause is procedural factors, including inadequate debridement of calcium before the valve was implanted.
|
|
Search Alerts/Recalls
|
|